Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia
CUKUROVA MEDICAL JOURNAL, cilt.47, sa.2, ss.715-721, 2022 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 2
- Basım Tarihi: 2022
- Doi Numarası: 10.17826/cumj.1085840
- Dergi Adı: CUKUROVA MEDICAL JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.715-721
- Anahtar Kelimeler: Immune thrombocytopenia, intravenous immunoglobulin, methylprednisolone, conventional prednisolone, treatment, INTERNATIONAL CONSENSUS REPORT, PURPURA, DEXAMETHASONE, EPIDEMIOLOGY, MANAGEMENT, CHILDREN
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Çukurova Üniversitesi Adresli: Hayır
Özet
Purpose: We aimed to compare the efficacy of high-dose methylprednisolone (HDP) with intravenous immunoglobulin (IVIG) and conventional prednisolone (CDP) as a first-line therapy in adult patients with immune thrombocytopenia (ITP).